Market Overview

Top 4 Large-Cap Stocks In The Biotechnology Industry With The Lowest PEG Ratio

Share:
Related GILD
Gilead Soothes Price War Worry With Q1 Results
Gilead Sciences Rallying Off Q1 Beat: A Technical Look
Gilead Sciences: Not Even Bears Can Spin These Results (Seeking Alpha)
Related CELG
Morgan Stanley Looks Over Celgene's Quarter
Analysis of REVLIMID in Patients with Non-Del-5Q MDS Demonstrated Improved Health Related Quality of Life Measures
Growth Names Pressured As IBD 50 Slumps 4% For Week (Investor's Business Daily)

Below are the top large-cap biotechnology stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Gilead Sciences (NASDAQ: GILD) has a PEG ratio of 0.62. Gilead Sciences' trailing-twelve-month revenue is $11.20 billion.

Celgene (NASDAQ: CELG) has a PEG ratio of 0.93. Celgene's trailing-twelve-month operating margin is 30.49%.

Alexion Pharmaceuticals (NASDAQ: ALXN) has a PEG ratio of 1.63. Alexion Pharma's trailing-twelve-month EPS is $1.27.

Biogen Idec (NASDAQ: BIIB) has a PEG ratio 1.67. Biogen Idec's trailing-twelve-month ROE is 23.90%.

Posted-In: Biotechnology Industry Large-Cap PEG ratioTrading Ideas

 

Related Articles (ALXN + BIIB)

Around the Web, We're Loving...

Get Benzinga's Newsletters